Robert K. Bradley

18.8k total citations · 3 hit papers
75 papers, 4.5k citations indexed

About

Robert K. Bradley is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Robert K. Bradley has authored 75 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 18 papers in Hematology and 7 papers in Immunology. Recurrent topics in Robert K. Bradley's work include RNA Research and Splicing (42 papers), RNA modifications and cancer (34 papers) and RNA and protein synthesis mechanisms (21 papers). Robert K. Bradley is often cited by papers focused on RNA Research and Splicing (42 papers), RNA modifications and cancer (34 papers) and RNA and protein synthesis mechanisms (21 papers). Robert K. Bradley collaborates with scholars based in United States, South Africa and United Kingdom. Robert K. Bradley's co-authors include Heidi Dvinge, Omar Abdel‐Wahab, Eun Hee Kim, Olga Anczuków, Christopher B. Burge, Lior Pachter, Sujatha Jagannathan, Ian Holmes, Jose Mario Bello Pineda and Simon Haas and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Robert K. Bradley

73 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment

2013 733 citations Carla Klattenhoff, Johanna C. Scheuermann et al. Cell profile →
RNA splicing factors as oncoproteins and tumour suppressors

2016 475 citations Heidi Dvinge, Eun Hee Kim et al. profile →
RNA splicing dysregulation and the hallmarks of cancer

2023 236 citations Robert K. Bradley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert K. Bradley United States	36	3.8k	1.2k	393	325	304	75	4.5k
Vincent Schulz United States	34	2.6k 0.7×	368 0.3×	323 0.8×	392 1.2×	328 1.1×	76	3.9k
Keiko Akagi United States	33	2.9k 0.7×	612 0.5×	270 0.7×	1.1k 3.3×	423 1.4×	54	3.8k
Allen Delaney Canada	25	3.0k 0.8×	1.2k 1.0×	221 0.6×	588 1.8×	393 1.3×	41	4.2k
Xin Gao China	30	2.4k 0.6×	382 0.3×	295 0.8×	414 1.3×	145 0.5×	87	3.3k
Patrick J. Paddison United States	31	5.1k 1.3×	1.1k 1.0×	127 0.3×	1.1k 3.3×	222 0.7×	66	6.0k
Richard A. Young United States	11	5.5k 1.4×	792 0.7×	238 0.6×	611 1.9×	357 1.2×	11	6.2k
Peter B. Rahl United States	19	8.2k 2.1×	1.3k 1.1×	464 1.2×	714 2.2×	637 2.1×	28	9.3k
Peter N. Cockerill United Kingdom	37	3.4k 0.9×	582 0.5×	566 1.4×	532 1.6×	280 0.9×	90	4.6k
Alla A. Sigova United States	14	5.6k 1.5×	1.4k 1.2×	225 0.6×	591 1.8×	1.2k 3.8×	20	6.4k
Michael H. Kagey United States	15	5.1k 1.3×	624 0.5×	188 0.5×	549 1.7×	457 1.5×	34	5.8k

Countries citing papers authored by Robert K. Bradley

Since Specialization

Citations

This map shows the geographic impact of Robert K. Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert K. Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert K. Bradley more than expected).

Fields of papers citing papers by Robert K. Bradley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert K. Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert K. Bradley. The network helps show where Robert K. Bradley may publish in the future.

Co-authorship network of co-authors of Robert K. Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of Robert K. Bradley. A scholar is included among the top collaborators of Robert K. Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert K. Bradley. Robert K. Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clough, Courtnee, Anna Gallì, Cristina Picone, et al.. (2025). Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes. Blood Advances. 9(12). 3044–3055.

Clough, Courtnee, Jason Kim, Anna Gallì, et al.. (2024). Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition. Blood Cancer Discovery. 5(5). 353–370. 8 indexed citations

Gabel, Austin M., et al.. (2024). Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivo. Nature Communications. 15(1). 959–959. 6 indexed citations

Pineda, Jose Mario Bello & Robert K. Bradley. (2023). DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers. eLife. 12. 5 indexed citations

Dunker, William, et al.. (2023). The proto-oncogene SRC phosphorylates cGAS to inhibit an antitumor immune response. JCI Insight. 8(12). 6 indexed citations

Wang, Eric, et al.. (2023). Abstract A04: Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia. Blood Cancer Discovery. 4(3_Supplement). A04–A04. 1 indexed citations

Benbarche, Salima, Bo Liu, Jeetayu Biswas, et al.. (2023). Synthetic Introns Identify the Novel RNA Splicing Factor GPATCH8 As Required for Mis-Splicing Induced By SF3B1 Mutations. Blood. 142(Supplement 1). 3–3. 1 indexed citations

North, Khrystyna, Salima Benbarche, Bo Liu, et al.. (2022). Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells. Nature Biotechnology. 40(7). 1103–1113. 38 indexed citations

Takao, Sumiko, Lauren Forbes, Shuyuan Cheng, et al.. (2021). Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia. eLife. 10. 34 indexed citations

10.

Clough, Courtnee, Joseph Pangallo, Janine O. Ilagan, et al.. (2021). Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome. Blood. 139(13). 2038–2049. 45 indexed citations

11.

Pangallo, Joseph, Jean‐Jacques Kiladjian, Bruno Cassinat, et al.. (2020). Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations. Blood. 135(13). 1032–1043. 11 indexed citations

12.

Taylor, Justin, Xiaoli Mi, Khrystyna North, et al.. (2020). Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood. 136(13). 1477–1486. 38 indexed citations

13.

Thomas, James D., Jacob T. Polaski, Qing Feng, et al.. (2020). RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exons. Nature Genetics. 52(1). 84–94. 72 indexed citations

14.

Dvinge, Heidi, Jamie Guenthoer, Peggy L. Porter, & Robert K. Bradley. (2019). RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing. Genome Research. 29(10). 1591–1604. 105 indexed citations

15.

Palangat, Murali, Dimitrios G. Anastasakis, Dennis Liang Fei, et al.. (2019). The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation. Genes & Development. 33(9-10). 482–497. 66 indexed citations

16.

Fei, Dennis Liang, Tao Zhen, Benjamin H. Durham, et al.. (2018). Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1. Proceedings of the National Academy of Sciences. 115(44). E10437–E10446. 58 indexed citations

17.

Dvinge, Heidi, Rhonda E. Ries, Janine O. Ilagan, et al.. (2014). Sample processing obscures cancer-specific alterations in leukemic transcriptomes. Proceedings of the National Academy of Sciences. 111(47). 16802–16807. 52 indexed citations

18.

Ilagan, Janine O., Aravind Ramakrishnan, Brian Hayes, et al.. (2014). U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Research. 25(1). 14–26. 210 indexed citations

19.

Klattenhoff, Carla, Johanna C. Scheuermann, Lauren E. Surface, et al.. (2013). Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment. Cell. 152(3). 570–583. 733 indexed citations breakdown →

20.

Bradley, Robert K., et al.. (2009). Evolutionary Modeling and Prediction of Non-Coding RNAs in Drosophila. PLoS ONE. 4(8). e6478–e6478. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact